$2.65 +0.14 (5.58%)

PetMed Express, Inc. (PETS)

PetMed Express, Inc. (PETS) is a leading online pharmacy specializing in the sale of prescription and non-prescription pet medications, health products, and supplies. The company operates primarily through its website, PetMD, providing pet owners with convenient access to veterinary-approved products and advice. Established in 1996, PetMed Express focuses on delivering quality pet healthcare solutions with a focus on customer service and convenience.

Dividend Yield 45.28%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
August 18, 2023$0.302023-08-112023-08-14
June 12, 2023$0.302023-06-052023-06-06
February 27, 2023$0.302023-02-162023-02-20
November 30, 2022$0.302022-11-172022-11-18
August 19, 2022$0.302022-08-112022-08-12

Dividends Summary

Company News

PetMed Express (PETS) Faces Investor Scrutiny Amid Filing Delays, Executive Departures, Admitted Accounting Rule Violations -- Hagens Berman
GlobeNewswire Inc. • Reed Kathrein • October 13, 2025

PetMed Express is under investigation for potential financial misconduct, including delayed financial reporting, revenue recognition issues, and executive resignations after a whistleblower complaint.

Fiverr International (FVRR) Matches Q1 Earnings Estimates
Zacks Investment Research • Zacks Equity Research • May 9, 2024

Fiverr (FVRR) delivered earnings and revenue surprises of 0% and 1.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Dividend Stocks: Cuts You Could Have Avoided
Seeking Alpha • Steven Cress • November 14, 2023

This article highlights three dividend stocks whose weak Dividend Safety Grades were highlighted well before cuts that could have been avoided. Read more here.

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga • Lisa Levin • October 31, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) gained 53.1% to $0.3264 after the comp...

PetMed's stock plunges to 19-year low as dividend yield to drop from 19% to zero
MarketWatch • MarketWatch • October 31, 2023

PetMed investors were suffering their worst day in 23 years, after the company reported disappointing quarterly results and said it would suspend its dividend.